We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
The protective mechanism of SIRT3 and potential therapy in acute kidney injury.
- Authors
Yuan, Jinguo; Zhao, Jin; Qin, Yunlong; Zhang, Yumeng; Wang, Anjing; Ma, Rui; Han, Mei; Hui, Yueqing; Guo, Shuxian; Ning, Xiaoxuan; Sun, Shiren
- Abstract
Acute kidney injury (AKI) is a complex clinical syndrome with a poor short-term prognosis, which increases the risk of the development of chronic kidney diseases and end-stage kidney disease. However, the underlying mechanism of AKI remains to be fully elucidated, and effective prevention and therapeutic strategies are still lacking. Given the enormous energy requirements for filtration and absorption, the kidneys are rich in mitochondria, which are unsurprisingly involved in the onset or progression of AKI. Accumulating evidence has recently documented that Sirtuin 3 (SIRT3), one of the most prominent deacetylases highly expressed in the mitochondria, exerts a protective effect on AKI. SIRT3 protects against AKI by regulating energy metabolism, inhibiting oxidative stress, suppressing inflammation, ameliorating apoptosis, inhibiting early-stage fibrosis and maintaining mitochondrial homeostasis. Besides, a number of SIRT3 activators have exhibited renoprotective properties both in animal models and in vitro experiments, but have not yet been applied to clinical practice, indicating a promising therapeutic approach. In this review, we unravel and summarize the recent advances in SIRT3 research and the potential therapy of SIRT3 activators in AKI.
- Subjects
ACUTE kidney failure; CHRONIC kidney failure; ENERGY metabolism; HOMEOSTASIS; OXIDATIVE stress
- Publication
QJM: An International Journal of Medicine, 2024, Vol 117, Issue 4, p247
- ISSN
1460-2725
- Publication type
Article
- DOI
10.1093/qjmed/hcad152